Clinical trial
Effect of a Six-Week Mindfulness-Based Intervention on Glycemic Control, Cardiovascular Autonomic Function, Anxiety, and Depression in Adults With Type 2 Diabetes: A Randomized Controlled Trial
NCT07936357 is registered in ClinicalTrials.gov with Universitas Sebelas Maret Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a Six-Week Mindfulness-Based Intervention on Glycemic Control, Cardiovascular Autonomic Function, Anxiety, and Depression in Adults With Type 2 Diabetes: A Randomized Controlled Trial
- Lead sponsor
- Universitas Sebelas Maret Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2025
- Completion date
- June 30, 2025
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety, depression, diabetic autonomic neuropathy, type 2 diabetes mellitus
Arms
As registered; 2 arms.
-
Mindfulness plus standard therapy
Participants continued their standard antidiabetic therapy and completed a six-week audio-guided mindfulness program delivered through WhatsApp.
-
Standard therapy
Participants continued their standard antidiabetic therapy without the mindfulness program.
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Change in glycated hemoglobin (HbA1c)
HbA1c (%) measured with a point-of-care analyzer (Afinion HbA1c, Abbott). Change was calculated as the 6-week value minus the baseline value.
-
Change in fasting blood glucose
Venous blood glucose after an 8-10-hour fast, measured with an enzymatic photometric method (mg/dL). Change was calculated as the 6-week value minus the baseline value.
-
Change in 2-hour postprandial blood glucose
Venous blood glucose 2 hours after a meal, measured with an enzymatic photometric method (mg/dL). Change was calculated as the 6-week value minus the baseline value.
Lead sponsor's other trials
Universitas Sebelas Maret Hospital, most recent start first.
Similar trials
Same condition (Diabetic Neuropathies) and phase, most recent start first.
+207 more trials See the condition page